Clinical Trial Update: Natural History of Netherton Syndrome

View source ↗

Summary

A natural history study of Netherton Syndrome (NCT05902663) sponsored by Boehringer Ingelheim has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Netherton Syndrome | Status: TERMINATED